About the 7th Annual Allogeneic Cell Therapies Summit
Uniting the Allogeneic Cell Therapy Community to Spearhead the Development of
Universally Accessible Therapies!
Join industry trailblazers at the 7th Annual Allogeneic Cell Therapies Summit as they discuss long anticipated allotransplantation technologies, novel advancements in cell expansion, and critical strategies in donor selection.
Get involved in this unmissable summit to learn and connect with pioneers including IN8Bio, Shinobi Therapeutics, Bristol Myers Squibb, Cell BioEngines and Takeda, as they pick up pace to develop life-changing off-the-shelf therapies for cancer, autoimmune disease, and more!
Attend the 7th Annual Allogeneic Cell Therapies Summit to
Enhance your understanding of allogeneic rejection by exploring key biological pathways and mitigation strategies with Shinobi Therapeutics and the Moffit Cancer Center
Supercharge your knowledge on scaling cell production to manufacture larger high-quality batches with with Be Biopharma and Glycostem
Dive into cutting-edge cell engineering techniques to improve cell persistence and potency with Synaptimmune and NKILT Therapeutics
Discuss the expanding applications of allogeneic therapies in autoimmune disease with Atara Bio and Adicet Bio to showcase how this field is breaking new therapeutic ground
Navigate the complexities of regulatory pathways and compliance challenges with practical guidance from Bristol Myers Squibb, Takeda, and the Alliance for Regenerative Medicine
"The networking opportunities were great. I had the chance to talk to many people in this field and get to know the players. The talks were also very relevant and informative”
Stemcell Technologies, 2024 Attendee
Who Will You Meet?
This meeting is your opportunity to connect with top allogeneic pioneers across the whole pipeline of product development from R&D, translational, medical, manufacturing, supply chain to regulatory experts.
Network with allogeneic cell therapy experts who are laser-focused on realizing the potential of accessible cell therapies for patients worldwide. Join experts from companies including:
"This is your chance to exchange, debate and discuss novel approaches to improve your current technologies and get them to patients faster and more effectively”
NKILT Therapeutics, 2025 Speaker